Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial
Robert D. Morgan, Susana Banerjee, Marcia Hall, Andrew R. Clamp, Cong Zhou, Jurjees Hasan, Cecilia Orbegoso, Sarah Taylor, Jonathan Tugwood, Alexander R. Lyon, Caroline Dive, Gordon Rustin, Gordon C. Jayson
Topics & Concepts
PazopanibMedicineTolerabilityInternal medicineDiscontinuationAdverse effectNeutropeniaBevacizumabNauseaRegimenPhases of clinical researchOncologyClinical trialCancerSunitinibChemotherapyOvarian cancer diagnosis and treatmentAngiogenesis and VEGF in CancerPARP inhibition in cancer therapy